Biolinq, Inc.
Biolinq, Inc. is a Needle-Free Blood Glucose Monitoring founded by Joshua Windmiller.
5
Funding Rounds
$138.3m
Money raised
Overview
Biolinq, Inc. is a Needle-Free Blood Glucose Monitoring founded by Joshua Windmiller.
- Website:
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ja*** Ta***** | - | - | |
| Jo**** Wi******** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Na*** A Ho** | - | - | linkedin twitter |
Funding series
Funding Series Analysis
The company Biolinq, Inc. has raised a total of $10m in funding over 5 rounds.
Key Insights:
- Biolinq, Inc. Series A round, November 2017: $10m
- Biolinq Inc funding round, September 2021: $109.51m
- Biolinq Inc funding round, April 2020: $8m
- Biolinq Inc funding round, March 2021: $6m
- Biolinq funding round, March 2019: $4.75m
Biolinq, Inc. Series A round, November 2017
$10m
Biolinq Inc funding round, September 2021
$109.51m
Biolinq Inc funding round, April 2020
$8m
Biolinq Inc funding round, March 2021
$6m
Biolinq funding round, March 2019
$4.75m
Industries
Biolinq, Inc. is active in the following industries:
- Biosensor
- Digital health
- Fitness
- Health technology
- Biomedical engineering
- Noninvasive glucose monitor
- Diabetes management
- Diabetes mellitus
- Technology
- Internet of things (IoT)
- Wearable technology
- Healthcare
- Biotechnology
- Engineering